All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Desensitization | NCIT_C155788 | [Any of various methods to reduce or eliminate an organism's negative reaction to a substance or stimulus.] |
| Burkitt Lymphoma with Plasmacytoid Differentiation | NCIT_C7189 | [Burkitt lymphoma characterized by the presence of malignant cells with eccentric basophilic cytoplasm. The nucleoli of these cells are often single and central. This morphologic variant of Burkitt lymphoma is more often seen in patients with immunodeficiency.] |
| Boron Neutron Capture Therapy | NCIT_C15378 | [A type of radiation therapy in which the patient is given an intravenous boron infusion that is absorbed by tumor cells. Radiation is then directed at the boron, killing the tumor cells but not the surrounding normal tissue.] |
| B-Cell Proliferation of Uncertain Malignant Potential | NCIT_C7182 | [A B-cell lymphoproliferative disorder with uncertain malignant potential. The representative example of this category is lymphomatoid granulomatosis.] |
| Premalignant Hematologic Condition | NCIT_C27274 | [A hematologic disorder which does not display the morphologic and/or clinical characteristics of an overt malignancy. Representative examples include atypical lymphoproliferative disorders and myelodysplastic syndromes.] |
| Teleradiology | NCIT_C15379 | [The transmission of radiology images by electronic means to facilitate collaborative interpretation.] |
| Telemedicine | NCIT_C15380 | [The use of telecommunications technology to provide, enhance, or expedite health care services, as by accessing off-site databases, linking clinics or physicians' offices to central hospitals, or transmitting x-rays or other diagnostic images for examination at another site. (Bartleby.com)] |
| Polymorphic Post-Transplant Lymphoproliferative Disorder | NCIT_C7183 | [A clonal B-cell lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by destructive infiltration of lymph nodes and extranodal sites by a polymorphic B-cell infiltrate composed of small and medium sized lymphocytes, immunoblasts, and plasma cells. In some cases, reduction of the immunosuppression therapy may lead to regression of the lesions. In other cases the lesions may progress to lymphoma.] |
| Methotrexate-Associated Lymphoproliferative Disorder | NCIT_C7184 | [A lymphoproliferative disorder that develops in patients who are immunosuppressed with methotrexate. This disorder is often Epstein-Barr virus positive, and morphologically it may resemble large B-cell non-Hodgkin lymphoma, Hodgkin lymphoma, or a polymorphous post-transplant lymphoproliferative disorder. (WHO, 2001)] |
| Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders | NCIT_C150684 | [Lymphoid proliferations or lymphomas that arise in patients treated with immunosuppressive drugs for autoimmune diseases or conditions other than in the post-transplant setting. (WHO 2017)] |
| Lymphoma | NCIT_C3208 | [A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.] |
| Peritoneal Gastrointestinal Stromal Tumor | NCIT_C40338 | [A gastrointestinal stromal tumor that arises from the peritoneum. This is an extragastrointestinal tumor, meaning that it does not arise directly from the gastrointestinal tract.] |
| Extragastrointestinal Gastrointestinal Stromal Tumor | NCIT_C27716 | [A rare gastrointestinal stromal tumor that presents as a solitary mass outside the gastrointestinal tract.] |
| Mesenteric Gastrointestinal Stromal Tumor | NCIT_C40339 | [A gastrointestinal stromal tumor that arises from the mesentery. This is an extragastrointestinal tumor, meaning that it does not arise directly from the gastrointestinal tract.] |
| VFQ25-Self Administered Format - Main Reason You Gave Up Driving | NCIT_C112787 | [Visual Functioning Questionnaire 25-Self Administered Format Version 2000 (VFQ25-Self Administered Format) Difficulty With Activities: If you gave up driving: Was that mainly because of your eyesight, mainly for some other reason, or because of both your eyesight and other reasons?] |
| VFQ25-Self Administered Format - Difficulty Driving During Daytime | NCIT_C112788 | [Visual Functioning Questionnaire 25-Self Administered Format Version 2000 (VFQ25-Self Administered Format) Difficulty With Activities: If currently driving: How much difficulty do you have driving during the daytime in familiar places? Would you say you have:] |
| Grade 4 Otitis Middle Ear Non Infectious, CTCAE | NCIT_C54980 | |
| VFQ25-Self Administered Format - Difficulty Driving at Night | NCIT_C112789 | [Visual Functioning Questionnaire 25-Self Administered Format Version 2000 (VFQ25-Self Administered Format) Difficulty With Activities: How much difficulty do you have driving at night? Would you say you have:] |
| Grade 4 Tinnitus, CTCAE | NCIT_C54981 | |
| Vulvar Congenital Melanocytic Nevus | NCIT_C40330 | [A nevus that arises from the vulva and is present at birth.] |